As for its upstream miRNAs, EPHA2 has been indicated to be targeted by different miRNAs to participate the development of various cancers, including non-small cell lung cancer [29], hepatocellular carcinoma [30] as well as colorectal cancer [31]. Here, EPHA2 is linked to hepatocellular carcinoma.